IMDX

Insight Molecular Diagnostics Inc. Common Stock
IMDX

Overview Fund Activity

26 hedge funds and large institutions have $21.8M invested in Insight Molecular Diagnostics Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
-7
Holders Change %
-21.21%
% of All Funds
0.6%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
4
Reduced
4
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DWM
1
Destination Wealth Management
California
$74K
2
Commonwealth Equity Services
2
Commonwealth Equity Services
Massachusetts
$60K
3
Morgan Stanley
3
Morgan Stanley
New York
$73K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.03M
5
Northern Trust
5
Northern Trust
Illinois
$37K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$79K
2
Goldman Sachs
2
Goldman Sachs
New York
$0
3
ECM
3
Element Capital Management
New York
$114K
4
PPA
4
Parametric Portfolio Associates
Washington
$0
5
PP
5
Paloma Partners
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Deutsche Bank
26
Deutsche Bank
Germany
– -$4K -76 Closed
Manulife (Manufacturers Life Insurance)
27
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$3K -61 Closed
UBS Group
28
UBS Group
Switzerland
– -$1K -19 Closed
1
2